Ad
related to: value based kidney care companies- Recommended Dosage
Discover Appropriate Dosage
to Treat Patients
- Kidney Transplant
Treatment for Kidney
Transplant Immunosuppression
- Storage & Handling
Learn to Properly Store and
Handle Treatment for Patients
- Kidney Transplant Therapy
Read About How Treatment May
Fight Against Acute Rejection
- Medical Experts
Watch Healthcare Professionals
Share Transplant Insights
- Recipients
Discover How Patients
May Benefit from Treatment
- Recommended Dosage
Search results
Results From The WOW.Com Content Network
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. [3] The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Fresenius Medical Care, a publicly traded company of which Fresenius owns 30.8%, focuses on patients with chronic kidney failure. [4] With its North American headquarters in Waltham, Massachusetts , it holds a 38% market share in the dialysis market in the United States.
The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. [5] By December 1996, DLJ had made a 386% return on its $10.5 million investment. [7] On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion ...
For premium support please call: 800-290-4726 more ways to reach us
List of United States dialysis providers: . Abramson Center for Jewish Life; American Renal Associates; American Renal Care; Atlantic Dialysis Management; BMA (BioMedical Applications)
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2] The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
NxStage Medical, Inc. (/ ˈ n ɛ k ˌ s t eɪ dʒ / NEK-stayj [2]) is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product. [1]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!